1998
DOI: 10.1099/00221287-144-8-2169
|View full text |Cite
|
Sign up to set email alerts
|

Membrane-bound and extracellular β-lactamase production with developmental regulation in Streptomyces griseus NRRL B-2682

Abstract: A new type ofβ-lactamase has been isolated and characterized in Streptomyces griseus NRRL B-2682. The enzyme has membrane-bound and extracellular forms. Biochemical characterization of some of the properties of the enzyme showed that it belongs to the class A group of penicillinases. Comparison of the membrane-bound and extracellular forms of theβ-lactamases suggests that they seem to be differently processed forms of the same enzyme. The N-terminal amino acid sequence of the extracellular form of the β-lactam… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

1999
1999
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 38 publications
0
9
0
Order By: Relevance
“…However, it should be noted that antibiotics may be broken down by adjacent bacteria on the PAO chip, and hence not all bacteria that grow are by definition resistant. For example, cefotaxime may be degraded through the secretion of a β-lactamase [54, 55]. We could hypothetise that the PAO chip acts as a buffer between the agar medium and the chip surface, thereby reducing the effective concentration of the antibiotic.…”
Section: Discussionmentioning
confidence: 99%
“…However, it should be noted that antibiotics may be broken down by adjacent bacteria on the PAO chip, and hence not all bacteria that grow are by definition resistant. For example, cefotaxime may be degraded through the secretion of a β-lactamase [54, 55]. We could hypothetise that the PAO chip acts as a buffer between the agar medium and the chip surface, thereby reducing the effective concentration of the antibiotic.…”
Section: Discussionmentioning
confidence: 99%
“…The peptide antibiotic globomycin specifically inhibits lipoprotein processing by binding to LspA in a non‐competitive manner (Dev et al ., 1985). Biochemical and physiological investigations indicate that globomycin inhibits lipoprotein processing in such diverse organisms as Synechococcus sp., Haemophilus ducreyi , Spiroplasma melliferum , Mycoplasma pneumoniae , Streptococcus zooepidemicus , Staphylococcus aureus and Streptomyces griseus (Maeda and Omata, 1997; Deak et al ., 1998; Gal et al ., 2001).…”
Section: Discussionmentioning
confidence: 99%
“…The work of Kimura et al (28) demonstrating that addition of D-alanyl-D-alanine to slowly sporulating subcultured cells accelerates sporulation is also consistent with this model. A similar model has been suggested to regulate processing and secretion of a ␤-lactamase in Streptomyces griseus (6). We have no evidence that the activity of ␤-lactamase itself is important in the reshaping of the peptidoglycan that happens during sporulation and germination, and current understanding of ␤-lactamases suggests that it is unlikely that the chromosomal ␤-lactamase of M. xanthus acts directly on peptidoglycan or its components (14).…”
Section: Discussionmentioning
confidence: 64%